Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Aug 15;90(16):7686–7690. doi: 10.1073/pnas.90.16.7686

Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen.

J Stagsted 1, C Mapelli 1, C Meyers 1, B W Matthews 1, C B Anfinsen 1, A Goldstein 1, L Olsson 1
PMCID: PMC47207  PMID: 8356070

Abstract

The stimulatory activity of peptides from the alpha 1 domain of the major histocompatibility complex (MHC) class I antigen on adipose cell glucose transport was previously shown to require a preformed, ordered conformation of the peptide. The two peptides studied previously were Dk-(61-85) (ERETQIAKGNEQSFRVDLRTLLRYY) and Dk-(69-85). We now show that systematic alanine substitution in Dk-(69-85) identifies residues that are essential for biological activity. Ordered structure of the peptides, estimated by circular dichroism, was found in all peptides with activity, but with a complex variety of spectra. Inactive peptides were in either a random coil or an ordered structure. Ordered structure, therefore, is not sufficient for activity. The peptides self-interact in the absence of cells and form aggregates that precipitate upon centrifugation. The tendency to aggregate is correlated with biological potency. Only MHC class I molecules have significant homology to the peptides studied here. The peptide self-interaction suggests that the biological effects in cells, which result from inhibition of receptor and transporter internalization, may be due to the binding (tantamount to self-interaction) of the peptide to the homologous sequences in the alpha 1 domain of the MHC class I molecule.

Full text

PDF
7686

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987 Oct 8;329(6139):506–512. doi: 10.1038/329506a0. [DOI] [PubMed] [Google Scholar]
  2. Chakrabarti A., Matko J., Rahman N. A., Barisas B. G., Edidin M. Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. Biochemistry. 1992 Aug 11;31(31):7182–7189. doi: 10.1021/bi00146a022. [DOI] [PubMed] [Google Scholar]
  3. Cunningham B. C., Wells J. A. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science. 1989 Jun 2;244(4908):1081–1085. doi: 10.1126/science.2471267. [DOI] [PubMed] [Google Scholar]
  4. Cunningham B. C., Wells J. A. Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3407–3411. doi: 10.1073/pnas.88.8.3407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johnson W. C., Jr Protein secondary structure and circular dichroism: a practical guide. Proteins. 1990;7(3):205–214. doi: 10.1002/prot.340070302. [DOI] [PubMed] [Google Scholar]
  6. Krishna S., Benaroch P., Pillai S. Tetrameric cell-surface MHC class I molecules. Nature. 1992 May 14;357(6374):164–167. doi: 10.1038/357164a0. [DOI] [PubMed] [Google Scholar]
  7. Madden D. R., Gorga J. C., Strominger J. L., Wiley D. C. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature. 1991 Sep 26;353(6342):321–325. doi: 10.1038/353321a0. [DOI] [PubMed] [Google Scholar]
  8. Stagsted J., Baase W. A., Goldstein A., Olsson L. A preformed, ordered structure of a 25-residue peptide derived from a major histocompatibility complex class I antigen is required to affect insulin receptor function. J Biol Chem. 1991 Jul 15;266(20):12844–12847. [PubMed] [Google Scholar]
  9. Stagsted J., Reaven G. M., Hansen T., Goldstein A., Olsson L. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell. 1990 Jul 27;62(2):297–307. doi: 10.1016/0092-8674(90)90367-n. [DOI] [PubMed] [Google Scholar]
  10. Stagsted J., Ziebe S., Satoh S., Holman G. D., Cushman S. W., Olsson L. Insulinomimetic effect on glucose transport by epidermal growth factor when combined with a major histocompatibility complex class I-derived peptide. J Biol Chem. 1993 Jan 25;268(3):1770–1774. [PubMed] [Google Scholar]
  11. Wells J. A. Systematic mutational analyses of protein-protein interfaces. Methods Enzymol. 1991;202:390–411. doi: 10.1016/0076-6879(91)02020-a. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES